-
1
-
-
30944466704
-
Overview of hemostatic factors involved in atherosclerotic cardiovascular disease
-
Kannel WB: Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005; 40: 1215-1220.
-
(2005)
Lipids
, vol.40
, pp. 1215-1220
-
-
Kannel, W.B.1
-
2
-
-
11144313064
-
Pathobiology of atherosclerosis - A brief review
-
Kher N, Marsh JD: Pathobiology of atherosclerosis - a brief review. Semin Thromb Hemost 2004; 30: 665-672.
-
(2004)
Semin Thromb Hemost
, vol.30
, pp. 665-672
-
-
Kher, N.1
Marsh, J.D.2
-
3
-
-
0042833280
-
Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes
-
Krysiak R, Okopien B, Herman Z: Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes. Drugs 2003; 63: 1821-1854.
-
(2003)
Drugs
, vol.63
, pp. 1821-1854
-
-
Krysiak, R.1
Okopien, B.2
Herman, Z.3
-
5
-
-
79551478959
-
Hemostatic effects of simvastatin in subjects with impaired fasting glucose
-
Krysiak R, Gdula-Dymek A, Okopien B: Hemostatic effects of simvastatin in subjects with impaired fasting glucose. Pharmacol Rep 2010; 62: 1090-1098.
-
(2010)
Pharmacol Rep
, vol.62
, pp. 1090-1098
-
-
Krysiak, R.1
Gdula-Dymek, A.2
Okopien, B.3
-
6
-
-
79959626820
-
Haemostatic effects of simvastatin in subjects with impaired glucose tolerance
-
Krysiak R, Okopien B: Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J 2011; 41: 473-481.
-
(2011)
Intern Med J
, vol.41
, pp. 473-481
-
-
Krysiak, R.1
Okopien, B.2
-
7
-
-
14244256766
-
Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia
-
Okopien B, Krysiak R, Madej A, Belowski D, Zieli?ski M, Kowalski J, Herman ZS: Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia. Pol J Pharmacol 2004; 56: 781-787.
-
(2004)
Pol J Pharmacol
, vol.56
, pp. 781-787
-
-
Okopien, B.1
Krysiak, R.2
Madej, A.3
Belowski, D.4
Zieliski, M.5
Kowalski, J.6
Herman, Z.S.7
-
9
-
-
84860255792
-
The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia
-
Krysiak R, Zmuda W, Okopien B: The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia. Fundam Clin Pharmacol 2012; 26: 424-431.
-
(2012)
Fundam Clin Pharmacol
, vol.26
, pp. 424-431
-
-
Krysiak, R.1
Zmuda, W.2
Okopien, B.3
-
10
-
-
78649371385
-
Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes
-
Krysiak R, Gdula-Dymek A, Bachowski R, Okopien B: Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes. Diabetes Care 2010; 33: 2266-2270.
-
(2010)
Diabetes Care
, vol.33
, pp. 2266-2270
-
-
Krysiak, R.1
Gdula-Dymek, A.2
Bachowski, R.3
Okopien, B.4
-
11
-
-
34548433987
-
Hypertriglyceridemia
-
Brunzell JD: Hypertriglyceridemia. N Engl J Med 2007; 357: 1009-1017.
-
(2007)
N Engl J Med
, vol.357
, pp. 1009-1017
-
-
Brunzell, J.D.1
-
12
-
-
81255137973
-
The role of triglycerides in atherosclerosis
-
Talayero BG, Sacks FM: The role of triglycerides in atherosclerosis. Curr Cardiol Rep 2011; 13: 544-552.
-
(2011)
Curr Cardiol Rep
, vol.13
, pp. 544-552
-
-
Talayero, B.G.1
Sacks, F.M.2
-
13
-
-
0032567990
-
Hypertriglyceridemia as a cardiovascular risk factor
-
Austin MA, Hokanson JE, Edwards KL: Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81(suppl 4A):7B-12B.
-
(1998)
Am J Cardiol
, vol.81
, Issue.SUPPL. 4A
-
-
Austin, M.A.1
Hokanson, J.E.2
Edwards, K.L.3
-
14
-
-
0023684354
-
Hypercoagulability and factor VII in hypertriglyceridemia
-
Mitropoulos KA: Hypercoagulability and factor VII in hypertriglyceridemia. Semin Thromb Hemost 1988; 14: 246-252.
-
(1988)
Semin Thromb Hemost
, vol.14
, pp. 246-252
-
-
Mitropoulos, K.A.1
-
15
-
-
0242585716
-
Blood coagulation
-
Dahlback B: Blood coagulation. Lancet 2000; 355: 1627-1632.
-
(2000)
Lancet
, vol.355
, pp. 1627-1632
-
-
Dahlback, B.1
-
16
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebocontrolled trial
-
Heart Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebocontrolled trial. Lancet 2002; 360: 7-22.
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
17
-
-
80051509128
-
Hemostatic effects of bezafibrate and ?-3 fatty acids in isolated hypertriglyceridemic patients
-
Krysiak R, Gdula-Dymek A, Okopien B: Hemostatic effects of bezafibrate and ?-3 fatty acids in isolated hypertriglyceridemic patients. Pharmacol Rep 2011; 63: 763-771.
-
(2011)
Pharmacol Rep
, vol.63
, pp. 763-771
-
-
Krysiak, R.1
Gdula-Dymek, A.2
Okopien, B.3
|